Literature DB >> 1880093

Progressive systemic sclerosis in south India.

V Krishnamurthy1, R Porkodi, S Ramakrishnan, C P Rajendran, R Madhavan, K Achuthan, M Parthiban, A N Chandrasekaran.   

Abstract

Seventy eight patients with progressive systemic sclerosis (PSS) were seen over a period of 14 years. They were analysed after clinical, haematological, biochemical, immunological and radiological investigations for comparison with other Indian and Western studies. Nine of the 78 were cases of childhood PSS. There was a female preponderance (3.9:1) and the peak age of occurrence was the 4th decade (32.1%). Arthralgia (53.8%) and skin thickening (70.5%) were the common presenting symptoms. Raynaud's phenomenon (28.2%) was less common. Involvement of the skin was present in all the patients and skin biopsy was positive in 96% of the cases. Joints were affected in 66.7%; internal organs were involved in 52.6%. Antinuclear antibody was positive in 56.8%. Abnormal echocardiography (37.6%) and barium studies (20.4%) were seen. Restrictive airway pattern by pulmonary function test was present in 55%. Death occurred in 5 patients, of whom 3 died of severe pulmonary hypertension.

Entities:  

Mesh:

Year:  1991        PMID: 1880093

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN: 0004-5772


  9 in total

1.  Unique clinical and autoantibody profile of a large Asian Indian cohort of scleroderma-do South Asians have a more aggressive disease?

Authors:  Ramya Janardana; Aswin M Nair; Ajit K Surin; John Anthony Jude Prakash; Mahasampath Gowri; Debashish Danda
Journal:  Clin Rheumatol       Date:  2019-07-15       Impact factor: 2.980

2.  Mucocutaneous and demographic features of systemic sclerosis: a profile of 46 patients from eastern India.

Authors:  Sudip Kumar Ghosh; Debabrata Bandyopadhyay; Indranil Saha; Jayanta Kumar Barua
Journal:  Indian J Dermatol       Date:  2012-05       Impact factor: 1.494

3.  Juvenile systemic sclerosis: experience from a tertiary care center from India.

Authors:  Narendra Kumar Bagri; Dinesh Raj; Jasmeet Kaur; Harish Punia; Isha Saini; Rakesh Lodha; S K Kabra
Journal:  Rheumatol Int       Date:  2017-08-22       Impact factor: 2.631

4.  Systemic scleroderma in Greece: low mortality and strong linkage with HLA-DRB1*1104 allele.

Authors:  P G Vlachoyiannopoulos; U G Dafni; I Pakas; M Spyropoulou-Vlachou; C Stavropoulos-Giokas; H M Moutsopoulos
Journal:  Ann Rheum Dis       Date:  2000-05       Impact factor: 19.103

5.  Juvenile onset systemic sclerosis: a single center experience of 23 cases from Asia.

Authors:  Ramnath Misra; Gurmeet Singh; Parshant Aggarwal; Amita Aggarwal
Journal:  Clin Rheumatol       Date:  2006-12-19       Impact factor: 3.650

Review 6.  Ethnicity and race and systemic sclerosis: how it affects susceptibility, severity, antibody genetics, and clinical manifestations.

Authors:  John D Reveille
Journal:  Curr Rheumatol Rep       Date:  2003-04       Impact factor: 4.686

7.  Clinical and autoimmune profile of scleroderma patients from Western India.

Authors:  Vandana Pradhan; Anjali Rajadhyaksha; Milind Nadkar; Pallavi Pandit; Prathamesh Surve; Maxime Lecerf; Jagadeesh Bayry; Srinivas Kaveri; Kanjaksha Ghosh
Journal:  Int J Rheumatol       Date:  2014-10-19

8.  Pulmonary involvement in systemic sclerosis: A clinical profile.

Authors:  A S Deepa; Roopa Premanand Rachel; Priya Ramchandran; Uma Devaraj; S Abhilash Arnold; Vineeta Shobha; George D'souza
Journal:  Lung India       Date:  2016 Mar-Apr

9.  Systemic sclerosis: current concepts in pathogenesis and therapeutic aspects of dermatological manifestations.

Authors:  Vishalakshi Viswanath; Meghana M Phiske; Vinay V Gopalani
Journal:  Indian J Dermatol       Date:  2013-07       Impact factor: 1.494

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.